Reversible posterior leukoencephalopathy syndrome in a patient with Takayasu arteritis

References

• Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. A study of 32 North American patients. Med (Baltimore) 1985; 64:89–99.
   PubMed Web of Science ®Google Scholar
• Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M et al. Takayasu arteritis. Ann Intern Med. 1994; 120:919–29.
   PubMed Web of Science ®Google Scholar
• Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55:481–6.
   PubMed Web of Science ®Google Scholar
• Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. 2005;75:110–7.
   PubMed Web of Science ®Google Scholar
• Ringleb PA, Strittmatter El, Loewer M, Hartmann M, Fiebach JB, Lichy C et al. Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology. 2005;44:1012–5.
   PubMedGoogle Scholar
• Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.
   PubMed Web of Science ®Google Scholar
• Pavlakis SG, Frank Y, Kafina P, Chandra M, Lu D. Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol. 1997;16:145–8.
   Google Scholar
• Delanty N, Vaughan C, Frucht S, Stubgen P. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurol-ogy. 1997;49:686–9.
   PubMed Web of Science ®Google Scholar
• Arai M, Shigeno K, Wada M. A reversible posterior leukoen-cephalopathy syndrome in a patient with classical polyarteritis nodosa. Clin Neurol. 1997;37:64–6.
   Google Scholar
• Schwartz RB, Mulkem RV, Gudbjartsson H, Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: Clues to pathogenesis. AJNR Am J Neuroradiol. 1998;19:859–62.
   PubMed Web of Science ®Google Scholar
• Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: Utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000;21:1199–206.
   PubMed Web of Science ®Google Scholar
• Mukherjee P, McKinstry RC. Reversible posterior leukoenceph-alopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology. 2001;219:756–65.
   PubMed Web of Science ®Google Scholar
• Primavera A, Audenino D, Mavilio N, Cocito L. Reversible posterior leukoencephalopathy syndrome in systemic lupus and vascufitis. Ann Rheum Dis. 2001;60:534–7.
   PubMed Web of Science ®Google Scholar
• Kawano H, Kimura E, Ishizaki M, Nishida Y, Matsumoto N, Yamashita T et al. Reversible posterior leukoencephalopathy syndrome in two patients with microscopic polyarteritis nodosa. Clin Neurol. 2002;42:949–53.
   Google Scholar
• Dy GK, Swaroop VS. 31-year-old woman with confusion and labile behavior. Mayo Clin Proc. 2002;77:557–60.
   PubMedGoogle Scholar
• Yong PFK, Hamour SMA, Bums A. Reversible posterior leu-koencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant. 2003;18:2660–2.
   Google Scholar
• Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RK. Is reversible posterior leukoencephalopathy with severe hyper-tension completely reversible in all patients? Pediatr Nephrol. 2003;18:1161–6.
   Google Scholar
• Mavragani CP, Vlachoyiannopoulos PG, Kosmas N, Boletis T, Tzioufas AG, Voulgarelis M. A case of reversible posterior leu-koencephalopathy syndrome after rituximab infusion. Rheumatology. 2004;43:1450–1.
   PubMed Web of Science ®Google Scholar
• Ohta T, Sakano T, Shiotsu M, Furue T, Ohtani H, Kinoshita Y et al. Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol. 2004;19:442–4.
   PubMedGoogle Scholar
• Shin KC, Choi H.T, Bae YD, Lee JC, Lee EB, Song YW. Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclo-sporine. J Clin Rheumatol. 2005;11:164–6.
   PubMedGoogle Scholar
• Thaipisuttikul I, Phanthumchinda K. Recurrent reversible pos-terior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol. 2005;252:230–1.
   PubMed Web of Science ®Google Scholar
• Pasupuleti DV, Miranda M, Vattipally V. Posterior reversible encephalopathy syndrome. Am Fam Phys. 2005;72:2430–2.
   PubMed Web of Science ®Google Scholar
• Metzler C, Lamprecht P, Hellmich B, Reuter M, Arlt AC, Gross WL. Leukoencepalopathy after treatment of Churg-Strauss syn-drome with interferon a. Ann Rheum Dis. 2005;64:1242–3.
   PubMed Web of Science ®Google Scholar
• Magnano MD, Bush TM, Herrera I, Altman RD. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2006;35:396–402.
   PubMed Web of Science ®Google Scholar
• MM L, Zwerling J, Ocava LC, Chen IA, Putterman C. Reversible posterior leukoencephalopathy syndrome in connective tissue diseases. Semin Arthritis Rheum. 2006;35:388–95.
   PubMedGoogle Scholar
• Kur JK, Esdaile JM. Posterior reversible encephalopathy syn-drome-an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 2006;33:2178–83.
   PubMed Web of Science ®Google Scholar
• Tajima Y, Matsumoto A. Reversible posterior leukoencephalop-athy syndrome in p-ANCA-associated vascufitis. Intern Med 2006;45:1169–71.
   PubMedGoogle Scholar
• Sasayama D, Shimojima Y, Gono T, Kaneko K, Matsuda M, Ikeda S. Henoch-Schonlein purpura nephritis complicated by reversible posterior leukoencephalopathy syndrome. Clin Rheu-matol 2007;26:1761–3.
   PubMedGoogle Scholar
• Ishimori ML, Pressman BD, Wallace DJ, Weisman MH. Pos-terior reversible encephalopathy syndrome: another manifestation of CNS SLE ? Lupus 2007;16:436–43.
   PubMedGoogle Scholar
• Zar T, Samson W, Palmisano J. Reversible posterior leukoen-cephalopathy syndrome (RPLS) in a patient with systemic lupus erythemtosus (SLE) and lupus nephritis. Nephrol Dial Transplant. 2007;22:2400–1.
   Google Scholar
• Mak A, Chan BP, Yeh IB, Ho RC, Boey ML, Feng PH et al. Neuropsychiatric lupus and Reversible posterior leukoencepha-lopathy syndrome: a challenging clinical dilemma. Rheumatology. 2008;47:256–62.
   PubMedGoogle Scholar
• Nishio M, Yoshioka K, Yamagami K, Morikawa T, Konishi Y, Hayashi N et al. Reversible posterior leukoencephalopathy syn-drome: a possible manifestation of Wegener's granulomatosis-mediated endothelial injury. Mod Rheumatol. 2008;18:309–14.
   PubMedGoogle Scholar
• Belizna C, Lartigue A, Favre J, Gilbert D, Tron F, Levesque H et al. Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphosp-holipid syndrome? Lupus. 2008;17:185–94.
   Google Scholar
• Eichhom J, Sima D, Thile B, Lindschau C, Turowski A, Schmidt H et al. Anti-endothelial cell antibodies in Takayasu arteritis. Circulation. 1996;94:2396–401.
   PubMedGoogle Scholar
• Frontera JA, Spellman JP, Mohr JP. Contrast-induced neurotox-icity and selective cortical injury. Cerebrovasc Dis. 2007;24:148–51.
   Google Scholar